Subscribe
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR RECOMBINANT POLIOMYELITIS VACCINE Download
- Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Download
- Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Download
- Monthly Return of Equity Issuer on Movements in Securities Download
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE Download
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR TDCP ADOLESCENT AND ADULT Download
- VOLUNTARY ANNOUNCEMENT RECOMBINANT COVID-19 XBB.1.5 VARIANT VACCINE FOR INHALATION (ADENOVIRUS TYPE 5 VECTOR) INCLUDED FOR EMERGENCY USE Download
- Monthly Return of Equity Issuer on Movements in Securities Download
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR RECOMBINANT ZOSTER VACCINE Download
- RESIGNATION OF CHIEF FINANCIAL OFFICER Download
